Compare · CVII vs SAGA
CVII vs SAGA
Side-by-side comparison of Churchill Capital Corp VII (CVII) and Sagaliam Acquisition Corp. (SAGA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CVII and SAGA operate in Blank Checks (Finance), so they compete in similar markets.
- CVII carries a market cap of $1.68B.
Churchill Capital Corp VII
Churchill Capital Corp VII focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.
Sagaliam Acquisition Corp.
Sagaliam Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the telecommunications, media, and technology industries. The company was incorporated in 2021 and is based in Los Angeles, California.
Latest CVII
- Amendment: SEC Form SC 13G/A filed by Churchill Capital Corp VII
- SEC Form 15-12G filed by Churchill Capital Corp VII
- Large owner Magnetar Financial Llc disposed of $90,084,438 worth of shares (8,306,005 units at $10.85) (SEC Form 4)
- Churchill Capital Corp VII filed SEC Form 8-K: Termination of a Material Definitive Agreement, Other Events, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
- SEC Form 25-NSE filed by Churchill Capital Corp VII
- Churchill Capital Corp VII and CorpAcq Mutually Agree to Terminate Business Combination
- SEC Form 10-Q filed by Churchill Capital Corp VII
- Churchill Capital Corp VII filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form DEFA14A filed by Churchill Capital Corp VII
- SEC Form DEFA14A filed by Churchill Capital Corp VII
Latest SAGA
- Sagaliam Acquisition Corp Launches Improved IPF Formula with Vitamin C in Pill and Lozenge Form and Addition of New Slimming Neutraceutical
- Sagaliam Acquisition Corp. Announces Novation Agreement with Enzolytics, Inc.
- SEC Form 25-NSE filed by Sagaliam Acquisition Corp.
- Sagaliam Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Financial Statements and Exhibits
- Sagaliam Acquisition To Delist From Nasdaq On March 6
- SAGALIAM ACQUISITION CORP. ANNOUNCES DELISTING OF COMMON SHARES FROM NASDAQ
- SEC Form 10-Q filed by Sagaliam Acquisition Corp.
- SEC Form SC 13G/A filed by Sagaliam Acquisition Corp. (Amendment)
- SEC Form SC 13G filed by Sagaliam Acquisition Corp.
- SEC Form 10-Q filed by Sagaliam Acquisition Corp.